These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode. Steffen LE; Du R; Gammon A; Mandelblatt JS; Kohlmann WK; Lee JH; Buys SS; Stroup AM; Campo RA; Flores KG; Vicuña B; Schwartz MD; Kinney AY Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1772-1780. PubMed ID: 28971986 [No Abstract] [Full Text] [Related]
18. Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population. Gilmore MJ; Leo MC; Amendola LM; Goddard KAB; Ezzell Hunter J; Joseph G; Kauffman TL; Rolf B; Shuster E; Zepp JM; Wilfond BS; Biesecker BB Transl Behav Med; 2024 Jun; 14(7):377-385. PubMed ID: 38190737 [TBL] [Abstract][Full Text] [Related]
19. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. Euhus DM; Smith KC; Robinson L; Stucky A; Olopade OI; Cummings S; Garber JE; Chittenden A; Mills GB; Rieger P; Esserman L; Crawford B; Hughes KS; Roche CA; Ganz PA; Seldon J; Fabian CJ; Klemp J; Tomlinson G J Natl Cancer Inst; 2002 Jun; 94(11):844-51. PubMed ID: 12048272 [TBL] [Abstract][Full Text] [Related]
20. Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital. Lee R; Beattie M; Crawford B; Mak J; Stewart N; Komaromy M; Esserman L; Shaw L; McLennan J; Strachowski L; Luce J; Ziegler J Genet Test; 2005; 9(4):306-12. PubMed ID: 16379544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]